Boomers Should Not ...
Health Care: Drugs
Astex Pharmaceuticals Inc (ASTX: NASDAQ)
$5.20 -0.43 | -7.64%
05/22/13 - 04:00 PM ET
1.30M / 1.79M
Vol / Avg. Vol:5.63 / 5.63
Open / Prev. Close:5.16 - 5.66
Today's Range:1.60 - 6.95
52 Wk Range:93.47%
Performance YTD:TheStreet Rating:
Portfolios with ASTX
- Portfolio NameUser Type
- UserMy SP portfolio
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserGopher Gold
- ContributorStocks Under-$10 Moving Hig...
Latest ASTX Headlines from TheStreet
- Astex Pharmaceuticals To Present At UBS Global Healthcare Conference 05.14.13 | 06:05 am
- Short Interest Moves 16% Higher For ASTX 05.10.13 | 03:05 pm
- Astex Pharmaceuticals Inc Stock Downgraded (ASTX) 05.01.13 | 05:05 am
- Astex Pharmaceuticals Reports 2013 First Quarter Financial Results 04.29.13 | 04:04 pm
- Astex Pharmaceuticals To Present At Needham Healthcare Conference 04.23.13 | 06:04 am
- Astex Pharmaceuticals To Announce 2013 First Quarter Financial Results On April 29th 04.22.13 | 06:04 am
- Astex Pharmaceuticals Provides SGI-110 Update 04.10.13 | 06:04 am
- Investing 'Systems' Take the Guesswork Out of Making Money 04.04.13 | 06:04 am
- Astex Pharmaceuticals Pipeline Data Presentations At AACR 04.03.13 | 06:04 am
- Astex Pharmaceuticals To Present At ROTH Conference 03.12.13 | 06:03 am
Press Releases for ASTX
- Astex Pharmaceuticals To Present At AACR Annual Meeting - Business Wire 03.29.12 | 06:03 am
- Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda - Business Wire 03.21.12 | 06:03 am
- Eisai Inc. Receives Complete Response Letter From The U.S. Food And Drug Administration For Dacogen® (decitabine) For Injection SNDA In Acute Myeloid Leukemia - Business Wire 03.06.12 | 09:03 pm
- Astex Pharmaceuticals Reports 2011 Fourth Quarter And Year-End Financial Results - Business Wire 03.05.12 | 04:03 pm
- Astex Pharmaceuticals To Announce 2011 Fourth Quarter And Year-End Financial Results On March 5, 2012 - Business Wire 02.28.12 | 06:02 am
- Astex Pharmaceuticals To Host Annual Analyst And Investor Day On March 27, 2012 - Business Wire 02.16.12 | 06:02 am
- FDA’s Oncologic Drugs Advisory Committee (ODAC) Votes To Not Support Benefit/Risk Profile Of DACOGEN® (decitabine) In Acute Myeloid Leukemia - Business Wire 02.09.12 | 01:02 pm
- Astex Pharmaceuticals Announces Presentations At Upcoming Conferences - Business Wire 02.06.12 | 06:02 am
- Astex Announces Early Transfer Of Epigenetics Project To GSK - Business Wire 01.16.12 | 06:01 am
- Astex Pharmaceuticals To Present At Biotech Showcase On January 9th - Business Wire 01.03.12 | 06:01 am
Partner Headlines for ASTX
- Biotech Stocks Get A Turbo Boost From Vertex - Seeking Alpha 04.20.13 | 09:04 am
- Astex Pharmaceuticals: Heading For New Highs On Strong Pipeline Momentum - Seeking Alpha 01.10.13 | 09:01 am
- Under Construction Rehash: Buy Acadia And Astex - Seeking Alpha 09.20.12 | 09:09 am
- Astex's Linear Rise Versus Peregrine's And Cell Therapeutics' Sudden Pop - Seeking Alpha 09.10.12 | 09:09 am
- One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers - Seeking Alpha 07.21.12 | 06:07 am
- 3 Rising Biotech Stars All Under $2/Share - Seeking Alpha 06.18.12 | 09:06 am
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
